Co-Authors
This is a "connection" page, showing publications co-authored by Luke Moore and Scott Pallett.
Connection Strength
4.042
-
Optimising the initial investigation of suspected cases of SARS-CoV-2 reinfection. Travel Med Infect Dis. 2021 Jul-Aug; 42:102078.
Score: 0.943
-
Point-of-care SARS-CoV-2 serological assays for enhanced case finding in a UK inpatient population. Sci Rep. 2021 03 12; 11(1):5860.
Score: 0.934
-
Structured serological testing is an essential component to investigating SARS-CoV-2 reinfection. Lancet Infect Dis. 2021 05; 21(5):598-599.
Score: 0.925
-
Serological assays for delayed SARS-CoV-2 case identification - Author's reply. Lancet Respir Med. 2020 10; 8(10):e74.
Score: 0.903
-
Point-of-care serological assays for delayed SARS-CoV-2 case identification among health-care workers in the UK: a prospective multicentre cohort study. Lancet Respir Med. 2020 09; 8(9):885-894.
Score: 0.223
-
SARS-CoV-2 lateral flow assays for possible use in national covid-19 seroprevalence surveys (React 2): diagnostic accuracy study. BMJ. 2021 03 02; 372:n423.
Score: 0.058
-
Clinical and laboratory evaluation of SARS-CoV-2 lateral flow assays for use in a national COVID-19 seroprevalence survey. Thorax. 2020 12; 75(12):1082-1088.
Score: 0.056